Test Price
2,000 AED✅ Home Collection Available
Multiple Myeloma FISH Panel (del(11q), del(13q), IgH, del(17p)) in Dubai
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% locus-specific probe sensitivity via ISO 15189 accredited processing.
- Sample Collection: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Oversight: Post-test telephonic guidance from a DHA-licensed specialist for integrated result interpretation.
- Insurance Verification: Direct billing confirmation via WhatsApp +971 54 548 8731 prior to scheduling.
Test Overview & Methodology
The Multiple Myeloma (MM) FISH Panel uses interphase fluorescence in-situ hybridization to detect four clinically significant chromosomal aberrations in plasma cell disorders: deletion of 11q, deletion of 13q, rearrangements of the immunoglobulin heavy chain (IgH) locus, and deletion of 17p. These genetic markers stratify disease risk, inform prognosis, and guide targeted therapy selection. Results are typically available within 5–7 business days.
| Feature | MM FISH Panel (Our Lab) | Conventional Karyotyping |
|---|---|---|
| Precision | >99% locus-specific probe targeting on interphase nuclei | 70–80% sensitivity (metaphase-dependent) |
| Method | Interphase FISH (fluorescence in-situ hybridization) | Metaphase chromosome banding analysis |
| Turnaround Time | 5–7 business days | 14–21 business days |
Physician Insight & Safety Protocols
“As a diagnostic radiology specialist, I emphasize that genetic profiling results must be correlated with imaging findings and clinical presentation. This panel offers high-resolution detection of myeloma-associated aberrations, but treatment decisions should always be made jointly with the managing hematologist.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notes for Patients
Do not alter or discontinue any prescribed medication, including anticoagulants or myeloma therapies, without prior consultation with your treating physician. Any changes to your medication regimen must be evaluated in the context of your complete clinical picture.
Exclusion Criteria and Urgent Care Guidance
- Exclusion: Active bleeding diathesis or concurrent anticoagulant therapy that requires specialized procedural precautions; emergency clinical scenarios where immediate treatment cannot be postponed for test results.
- Emergency Red Flags: Acute onset of severe bone pain, new pathological fractures, signs of hypercalcemia (confusion, nausea, vomiting), or rapid renal function decline require immediate emergency assessment—do not delay care to schedule this test.
Patient FAQ & Clinical Guidance
1. What does the MM FISH Panel detect in multiple myeloma?
The panel identifies four specific chromosomal abnormalities—del(11q), del(13q), IgH rearrangements, and del(17p)—that are established prognostic markers in plasma cell disorders. The results help your hematologist classify disease risk as standard or high and tailor therapy accordingly.
2. How is the sample obtained and what preparation is needed?
A bone marrow aspirate is required for definitive analysis; this is performed by a qualified clinician in a hospital setting under sterile conditions. No fasting or special preparation is needed, but a valid physician referral is mandatory. Peripheral blood may be used in select cases where bone marrow is not accessible.
3. Will my health insurance cover this test in the UAE?
Most UAE health insurers provide coverage for the MM FISH Panel when it is medically indicated under oncology protocols. Our team conducts a pre-authorization verification via WhatsApp at +971 54 548 8731 to confirm your coverage and eliminate unexpected out-of-pocket costs.
4. What is the turnaround time and how will I receive results?
Results are delivered within 5–7 business days from sample receipt. A secure digital report is provided, and a telephonic consultation with a DHA-licensed specialist is included to explain the clinical implications of the findings in the context of your overall care plan.
UAE Regulatory & Data Privacy Adherence
Trust and Compliance Framework
- All patient data is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical testing safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Laboratory operations are ISO 15189 accredited and licensed by the Dubai Health Authority (DHA) under Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | Multiple Myeloma FISH Panel (del(11q), del(13q), IgH, del(17p)) |
| Price (AED) | 2,000 |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Bone marrow aspirate (primary); peripheral blood (alternative) |
| Methodology Used | Interphase Fluorescence In-Situ Hybridization (FISH) |
| ICD-10-CM Code | C90.0 (Multiple myeloma) |
| LOINC Code | 53756-8 (FISH multiple myeloma panel) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians